Business
Baird Medical Engages Global Clinical Leaders at AAES 2025
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place from May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.
About this update from Baird Medical Investment Holdings Ltd
[{"type":"text","content":"NEW YORK, May 19, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place from May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.","length":429,"tagName":"p"},{"type":"image","alt":"AAES 2025","displaySize":"","headline":null,"caption":"AAES 2025","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":250,"url":"https://media.zenfs.com/en/prnewswire.com/131fcd9c63740cbbf6546ca2fd5524fb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/vsompHGJkJfnFjvCqVWolQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ0MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/131fcd9c63740cbbf6546ca2fd5524fb","width":400,"height":250}},"href":"https://mma.prnewswire.com/media/2690390/BDMD_AAES_2025.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The AAES Annual Meeting, a premier academic and clinical forum, convenes leading endocrine surgeons, researchers, and innovators globally to explore advancements in endocrine surgery. For Baird Medical, this event is a key platform to showcase its latest MWA technological achievements and to foster direct engagement with healthcare professionals, thereby gaining deeper insights into the evolving needs of the medical community.","length":430,"tagName":"p"},{"type":"text","content":"At this year's meeting, Baird Medical presented its pioneering MWA system for thyroid nodule treatment, emphasizing its benefits as a minimally invasive alternative to conventional surgery. The technology garnered considerable interest from attending surgeons, who recognized its potential to enhance patient outcomes by minimizing procedural risks, preserving thyroid function, and expediting recovery. Through substantive dialogues with clinical experts, Baird Medical acquired critical feedback on practical aspects including patient selection, ultrasound guidance optimization, and diverse application scenarios.","length":620,"tagName":"p"},{"type":"text","content":"The insights and perspectives gathered at AAES 2025 are pivotal for shaping Baird Medical's future clinical collaboration...